As a result of enhanced uptake we could detect improved T-cell responses with potential anti-tumor activity, not only by activation of a gp100 specific CD8+ T-cell clone, but also by activation of iNKT and priming of MART-126−35L reactive T-cells. This evidence concerns the gene SEPTIN4 and neoplasm.